180 Life Sciences Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)					1 Months Ended						3 Months Ended	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Dec. 08, 2021	Aug. 04, 2021	Dec. 03, 2020	Nov. 25, 2020	Sep. 30, 2021	Aug. 31, 2021	Feb. 26, 2021	Feb. 19, 2021	Dec. 18, 2020	Oct. 17, 2017	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Aug. 23, 2021	Nov. 06, 2020
Stockholders' Equity (Details) [Line Items]
Preferred stock shares authorized (in Shares)												5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)												$ 0.0001	$ 0.0001
Stated value												$ 3,333,333
Stated value												333,333
Cash issuance cost												318,333
Warrant issuance costs												103,402
Fair value of bifurcated redemption feature				$ 218,000								1,167,000
Issuance reduced conversion price description				On November 25, 2020, a dilutive issuance reduced the conversion price to the lower of (a) 96% of the lowest volume-weighted-average-price of the common stock during the five-day period preceding the conversion date; or (b) $5.28, both subject to a floor of $2.00 per share.
Fair value of derivative liabilities				$ 606,000
Carrying value of the preferred stock				1,411,265
Derivative liabilities				1,773,000								15,220,367	$ 4,442,970
Fair value of the preferred stock				3,531,924
Deemed dividend income				$ 565,659
Stockholders’ equity , description									During the period from November 30, 2020 to December 18, 2020, the 1,000,000 shares of Series A Preferred of the Company with a total conversion value of $3,666,667 were converted into shares of the Company’s common stock at conversion prices of between $2.00 and $2.31 per share, pursuant to the terms of such preferred stock. The bifurcated redemption features were marked-to-market just prior to each conversion, resulting in an aggregate charge of $42,068 to change in fair value of derivative liabilities and the $260,068 fair value of the bifurcated redemption features were derecognized on the conversion dates. At conversion, the aggregate $3,531,924 carrying value of the preferred stock and the $260,068 fair value of the derivative liability were derecognized and we recognized the $4,349,035 fair value of the 1,614,144 shares of common stock issued. The difference of $557,043 was recorded as deemed dividend expense, including $333,333 associated with the make-whole premiums and $223,710 associated with the contingent beneficial conversion feature. Due to such conversions, the Company currently has no shares of Series A Preferred issued or outstanding.
Dividend												333,333
Beneficial conversion feature												223,710
Extinguishment on gain												$ 565,659
Common stock shares authorized (in Shares)												100,000,000	100,000,000
Par value per share (in Dollars per share)												$ 0.0001	$ 0.0001
Common stock shares issued (in Shares)													12,324,300
Cash issued in shares (in Shares)													12,292
Officers compensation													$ 1,057,989
Shareholder shares (in Shares)													1,519,628
Common stock share conversion (in Shares)													1,619,144
Preferred stock amounts													$ 4,349,035
Exchange common stock (in Shares)													1,521,157
Preferred stock conversion (in Shares)													482,894
Conversion debt (in Shares)													180
Recapitalization shares issued (in Shares)													6,928,645
Warrants exercise price (in Dollars per share)						$ 7.5						$ 5
Warrants term						5 years						5 years
Placement agent fees and offering expenses												$ 968,930
Allocated to common stock												364,812
Allocated to warrant liabilities												604,118
Purchasers aggregate amount												174,993
Maximum purchase aggregate amount												583,310
Incurred damages												$ 524,979
Price per share (in Dollars per share)											$ 2.73
Conversion price (in Dollars per share)															$ 2
Cash payment										$ 275,000
Restricted shares, issued (in Shares)										225,000
Grant date value										$ 1,973,250
Accounts payable										1,750,000
Gain (loss) on settlement of liabilities										$ 223,250
Placement agent fees and offering expenses						$ 1,120,000
Special voting shares (in Shares)												1,464,545
Purchase of aggregate shares (in Shares)	675,000	436,000					1,580,000
Options exercisable (in Dollars per share)	$ 3.95	$ 7.56	$ 2.49				$ 4.43
Aggregate grant date value	$ 2,077,953	$ 2,180,375	$ 93,575				$ 4,810,527
Granted options		10 years					10 years
Vest rate percentage							20.00%
Grant rate percentage							80.00%
Weighted average remaining vesting period		4 years										3 years 14 days
Vest years	4 years
Stock based compensation expense												$ 2,852,309	$ 7,798
Unrecognized stock based compensation expense												$ 6,302,356
Board of Directors [Member]
Stockholders' Equity (Details) [Line Items]
Purchase of aggregate shares (in Shares)			50,000
Conversions [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate principal amount											$ 365,750
Aggregate accrued interest											$ 66,633
Aggregate shares of common stock (in Shares)											158,383
Convertible Notes [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate principal amount											$ 1,234,333
Aggregate accrued interest											$ 105,850
Aggregate shares of common stock (in Shares)											467,123
Shares issued for common stock (in Shares)					150,000
Warrants to purchase shares (in Shares)					25,000
Convertible Notes [Member] \| Related Party Loans [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate principal amount					$ 693,371
Aggregate accrued interest					$ 157,741
Aggregate shares of common stock (in Shares)					141,852
Conversion price (in Dollars per share)					$ 6
Common Stock Issued for Services [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate shares (in Shares)												317,553
Aggregate issuance date fair value												$ 1,785,366
Series A Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock shares authorized (in Shares)															5,000,000
Preferred stock, par value (in Dollars per share)															$ 0.0001
Conversion price, per share (in Dollars per share)												$ 5.28
Dividend												10.00%
Shares issued (in Shares)												1,000,000
Shares outstanding (in Shares)												1,000,000
Carrying value of preferred stock												$ 1,411,265
Net of preferred stock												$ 1,922,068
Preferred Class A [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock shares authorized (in Shares)												1	1
Preferred shares issued (in Shares)												1	1		1,000,000
Designated shares (in Shares)															1
Voting share (in Shares)															1
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Beneficial ownership interest						4.99%						4.99%
Minimum [Member] \| Convertible Notes [Member]
Stockholders' Equity (Details) [Line Items]
Conversion price (in Dollars per share)											$ 2.45
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Beneficial ownership interest						9.99%						9.99%
Maximum [Member] \| Convertible Notes [Member]
Stockholders' Equity (Details) [Line Items]
Conversion price (in Dollars per share)											$ 3.29
Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Par value per share (in Dollars per share)								$ 4.55						$ 6
Aggregate shares (in Shares)								2,564,000
Aggregate gross proceeds						$ 15,000,000		$ 11,700,000
Offering expenses						$ 13,900,000		$ 10,700,000
Aggregate shares of common stock (in Shares)														2,500,000
Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate shares (in Shares)								2,564,000
Allocated to warrant liabilities												$ 604,118
Warrants shares (in Shares)														2,500,000